KILITCHBSEKilitch Drugs India LtdLowNeutral
Announced Thu, 7 May · 11:51 IST

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the audited financial results ....

KILITCH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹154.99
prior close
₹154.39
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.5+0.6+0.7+4.2+1.4-5.1+2.3+0.9+8.1+16.1+7.7+18.7
Up moveDown movePending
AI summary

Kilitch Drugs India Ltd has notified stock exchanges that its Board of Directors will meet on May 15, 2026 to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The company has closed its trading window from April 1, 2026 as per SEBI insider trading regulations, and it will reopen 48 hours after the financial results are disclosed to the exchanges. This is a standard regulatory intimation filed under SEBI Listing Regulations.

Likely market impact

This is a routine board meeting notice for annual/quarterly results. The stock is currently in a trading blackout period. Shareholders should expect the audited FY2026 results to be released shortly after the May 15 board meeting.